The head of USC Stem Cell Center, Chuck Murry, and his team will test a stem cell-based therapy designed to regenerate damaged tissue after a heart attack.
The researchers discovered an unrecognized developmental axis and engineered organizer cells to recreate key developmental signals.
Researchers develop a way to grow and genetically engineer the progenitor cells that give rise to macrophages, a type of first-responder immune cell that shows promise for developing immunotherapies for cancers and other diseases.
USC’s stem cell program prepares students to present research and become the regenerative medicine workforce of the future.
Building on the concept that blocking differentiation into specialized cell types maintains stem cells, USC and NIH scientists identify GSK3α as a checkpoint across diverse stem cell types.
Four scholarship recipients combine medicine with mentorship and science with service.
Keck Medicine of USC researchers are investigating a unique therapy that aims to repair damaged brain cells.
The center — a collaboration between the Keck School of Medicine of USC and the USC Viterbi School of Engineering — will use stem cell engineering to uncover disease mechanisms and advance new therapies.
Insights about brain cell damage after stroke and repair after transplant could pave the way for therapies that extend the treatment window, a USC lab study reveals.
Scientists discover that egg yolk is a key to establishing authentic embryonic stem cells from chickens and seven other avian species, as reported in Nature Biotechnology.
